These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7920160)

  • 81. PCR-based construction of long hammerhead ribozymes.
    Zillmann M; Robinson G
    Methods Mol Biol; 1997; 74():131-9. PubMed ID: 9204428
    [No Abstract]   [Full Text] [Related]  

  • 82. Development of ribozymes that target stathmin, a major regulator of the mitotic spindle.
    Mistry SJ; Benham CJ; Atweh GF
    Antisense Nucleic Acid Drug Dev; 2001 Feb; 11(1):41-9. PubMed ID: 11258620
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Oncogenes, onco-suppressors, carcinogenesis and oral cancer.
    Scully C
    Br Dent J; 1992 Jul; 173(2):53-9. PubMed ID: 1386990
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [Effects of antisense human telomerase RNA on growth of human gastric cancer cells].
    Zhang F; Zhang X; Fan D; Deng Z; Yan y ; Wu H
    Zhonghua Bing Li Xue Za Zhi; 2000 Oct; 29(5):367-9. PubMed ID: 11866938
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Catalytic antisense RNAs produced by incorporating ribozyme cassettes into cDNA.
    Tabler M; Tsagris M
    Gene; 1991 Dec; 108(2):175-83. PubMed ID: 1660835
    [TBL] [Abstract][Full Text] [Related]  

  • 86. A combination anti-HIV-1 gene therapy approach using a single transcription unit that expresses antisense, decoy, and sense RNAs, and trans-dominant negative mutant Gag and Env proteins.
    Ding SF; Lombardi R; Nazari R; Joshi S
    Front Biosci; 2002 Feb; 7():a15-28. PubMed ID: 11815282
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Tumor suppressor genes: prospects for cancer therapies.
    Bertelsen AH; Beaudry GA; Stoller TJ; Trotta PP; Sherman MI
    Biotechnology (N Y); 1995 Feb; 13(2):127-31. PubMed ID: 9634753
    [No Abstract]   [Full Text] [Related]  

  • 88. The versatility of RNA: let's shoot the deputy.
    Luft FC
    J Mol Med (Berl); 1998; 76(12):791-3. PubMed ID: 9846948
    [No Abstract]   [Full Text] [Related]  

  • 89. "Rules" to the genetic progression of tumours deciphered: Is it time to think differently in treating oral cancer patients?
    Mony U; Priya Veeraraghavan V
    Oral Oncol; 2022 Nov; 134():106111. PubMed ID: 36096047
    [No Abstract]   [Full Text] [Related]  

  • 90. Oral microbiome; a potential game-changer in the management of oral cancer?
    Devaraja K; Kabekkodu SP
    Oral Oncol; 2022 Apr; 127():105822. PubMed ID: 35290832
    [No Abstract]   [Full Text] [Related]  

  • 91. Assessment of oral dysfunction after oral cancer treatment.
    Yu C; Zhou Z
    Oral Oncol; 2022 Oct; 133():106046. PubMed ID: 35908361
    [No Abstract]   [Full Text] [Related]  

  • 92. In vitro studies of liposome-mediated gene transfer into head and neck cancer cell lines.
    Wollenberg B; Lang S; Schmitt B; Kastenbauer E; Zeidler R
    Eur Arch Otorhinolaryngol; 1997; 254 Suppl 1():S130-2. PubMed ID: 9065647
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Gene therapy for oral cancer: recent progress in research.
    Shillitoe EJ
    Oral Oncol; 1998 May; 34(3):157-60. PubMed ID: 9692048
    [No Abstract]   [Full Text] [Related]  

  • 94. Effects on tumor cells of ribozymes that cleave the RNA transcripts of human papillomavirus type 18.
    Chen Z; Kamath P; Zhang S; St John L; Adler-Storthz K; Shillitoe EJ
    Cancer Gene Ther; 1996; 3(1):18-23. PubMed ID: 8785706
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Antisense RNA to the putative tumor suppressor gene "deleted in colorectal cancer" transforms fibroblasts.
    Lawlor KG; Telang NT; Osborne MP; Schaapveld RQ; Cho KR; Vogelstein B; Narayanan R
    Ann N Y Acad Sci; 1992 Oct; 660():283-5. PubMed ID: 1340136
    [No Abstract]   [Full Text] [Related]  

  • 96. The impact of gene therapy on dentistry.
    Baum BJ; O'Connell BC
    J Am Dent Assoc; 1995 Feb; 126(2):179-89. PubMed ID: 7860886
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Gene therapy--its potential in the management of oral cancer.
    Shillitoe EJ; Lapeyre JN; Adler-Storthz K
    Eur J Cancer B Oral Oncol; 1994 May; 30B(3):143-54. PubMed ID: 7920160
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Gene therapy for the treatment of oral squamous cell carcinoma.
    Xi S; Grandis JR
    J Dent Res; 2003 Jan; 82(1):11-6. PubMed ID: 12508038
    [TBL] [Abstract][Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.